Jane Street’s ProShares UltraShort Health Care RXD Stock Holding History

Jane Street’s Portfolio RXD Stock Details RXD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-221,550	Closed	-$8.01M	–	10301
2024 Q2	$8.01M	Sell	221,550 -482,700	-69%	-$10.6M	﹤0.01%	2294
2024 Q1	$43.7M	Sell	704,250 -2,610,100	-79%	-$56.9M	0.01%	702
2023 Q4	$165M	Buy	3,314,350 +1,883,650	+132%	+$49.6M	0.04%	264
2023 Q3	$86.5M	Sell	1,430,700 -392,600	-22%	-$9.84M	0.03%	369
2023 Q2	$77.9M	Buy	1,823,300 +220,550	+14%	+$5.58M	0.03%	428
2023 Q1	$74.7M	Buy	1,602,750 +1,600	+0.1%	+$41.1K	0.03%	377
2022 Q4	$79.1M	Buy	1,601,150 +885,450	+124%	+$22.5M	0.04%	363
2022 Q3	$33.3M	Sell	715,700 -51,850	-7%	-$1.4M	0.01%	722
2022 Q2	$28.2M	Buy	+767,550	New	+$20.8M	0.01%	870

Other funds holding RXD

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's RXD Position: Q4 2019 in Review

Jane Street sold out of ProShares UltraShort Health Care (RXD) in Q4 2019, closing a stake of 2,880 shares — an estimated $259K sold.

Jane Street first reported a position in RXD in Q2 2017 and held it in 3 quarters. The position peaked at $268K in Q2 2017. 3 funds tracked by Wall St. Rank hold RXD as of Q4 2019.

Jane Street reported no remaining ProShares UltraShort Health Care position as of Q4 2019 after selling out during the quarter.
Jane Street sold 2,880 ProShares UltraShort Health Care shares in Q4 2019, an estimated $259K.
Jane Street first reported a position in ProShares UltraShort Health Care in Q2 2017 and held it in 3 quarters.
Jane Street's ProShares UltraShort Health Care position peaked at $268K in Q2 2017.
3 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q4 2019.

Based on Jane Street's 13F filing for Q4 2019, filed 14 Feb 2020.